PL2101826T3 - Znakowane izotopowo związki na bazie peptydów i ich zastosowania - Google Patents

Znakowane izotopowo związki na bazie peptydów i ich zastosowania

Info

Publication number
PL2101826T3
PL2101826T3 PL07860908T PL07860908T PL2101826T3 PL 2101826 T3 PL2101826 T3 PL 2101826T3 PL 07860908 T PL07860908 T PL 07860908T PL 07860908 T PL07860908 T PL 07860908T PL 2101826 T3 PL2101826 T3 PL 2101826T3
Authority
PL
Poland
Prior art keywords
based compounds
peptide based
radiolabelled peptide
diseases
compounds
Prior art date
Application number
PL07860908T
Other languages
English (en)
Inventor
Torgrim Engell
Steven Fairway
Ingrid Henriksen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of PL2101826T3 publication Critical patent/PL2101826T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL07860908T 2006-12-11 2007-12-11 Znakowane izotopowo związki na bazie peptydów i ich zastosowania PL2101826T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86938206P 2006-12-11 2006-12-11
PCT/NO2007/000434 WO2008072973A2 (en) 2006-12-11 2007-12-11 Radiolabelled peptide based compounds and uses thereof
EP07860908A EP2101826B1 (en) 2006-12-11 2007-12-11 Radiolabelled peptide based compounds and uses thereof

Publications (1)

Publication Number Publication Date
PL2101826T3 true PL2101826T3 (pl) 2010-11-30

Family

ID=39252990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07860908T PL2101826T3 (pl) 2006-12-11 2007-12-11 Znakowane izotopowo związki na bazie peptydów i ich zastosowania

Country Status (15)

Country Link
US (1) US20100322857A1 (pl)
EP (1) EP2101826B1 (pl)
JP (1) JP2010512310A (pl)
KR (1) KR20090097868A (pl)
CN (2) CN102321154A (pl)
AT (1) ATE471724T1 (pl)
AU (1) AU2007332210A1 (pl)
BR (1) BRPI0720257A2 (pl)
CA (1) CA2671564A1 (pl)
DE (1) DE602007007362D1 (pl)
ES (1) ES2346595T3 (pl)
MX (1) MX2009006028A (pl)
PL (1) PL2101826T3 (pl)
RU (1) RU2009119917A (pl)
WO (1) WO2008072973A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027584A1 (ja) * 2009-09-04 2011-03-10 国立大学法人京都大学 膵島イメージング用分子プローブ及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
DE60111733T2 (de) * 2000-04-12 2006-05-18 Amersham Health As Integrinbindende peptidderivate
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
WO2003006491A2 (en) * 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
NO20030115D0 (no) * 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods

Also Published As

Publication number Publication date
BRPI0720257A2 (pt) 2014-02-25
DE602007007362D1 (de) 2010-08-05
CN101563108A (zh) 2009-10-21
KR20090097868A (ko) 2009-09-16
ATE471724T1 (de) 2010-07-15
WO2008072973A3 (en) 2009-05-22
ES2346595T3 (es) 2010-10-18
WO2008072973A2 (en) 2008-06-19
CN101563108B (zh) 2012-07-18
MX2009006028A (es) 2009-06-17
JP2010512310A (ja) 2010-04-22
US20100322857A1 (en) 2010-12-23
CA2671564A1 (en) 2008-06-19
RU2009119917A (ru) 2011-01-20
AU2007332210A1 (en) 2008-06-19
EP2101826B1 (en) 2010-06-23
EP2101826A2 (en) 2009-09-23
CN102321154A (zh) 2012-01-18

Similar Documents

Publication Publication Date Title
BRPI0412986A (pt) composto, método para o diagnóstico ou formação de imagem in vivo de uma doença ou condição associadas com a angiogênese, formulação radiofarmacêutica, método para a preparação de um composto, e, kit para a preparação de um peptìdeo radiofluorado
Kuil et al. Imaging agents for the chemokine receptor 4 (CXCR4)
BR0210886A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
BRPI0515175A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um conjugado radiorrotulado ou um sal do mesmo, método para diagnose ou formação de imagem in vivo de uma doença ou condição associada com a angiogênese, e, método para monitorar o efeito do tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
ATE519776T1 (de) Peptidische verbindungen
JP2009537624A5 (pl)
BR0110748A (pt) Plataforma de nanodispositivo multifuncional
PT1472541E (pt) Agentes de imagiologia e métodos de imagiologia de naaladase de psma
WO2008075040A3 (en) Radioactive pet agents for imaging ccr5 in vivo
WO2001082864A3 (en) 18f-labeled choline analogs
Huang et al. Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models
EP1706145A4 (en) AUTOANTIC BODY USED IN TUMOR IMAGING AND CANCER TREATMENT AS A CARRIER FOR PHARMACEUTICAL COMPOUNDS
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
Aranda-Lara et al. Improved radiopharmaceutical based on 99mTc-Bombesin–folate for breast tumour imaging
CN103998929A (zh) 选择患者的方法
PL2101826T3 (pl) Znakowane izotopowo związki na bazie peptydów i ich zastosowania
IL159479A (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2003104761A3 (en) MEASUREMENT OF MELANOCORTINE PEPTIDES AND USES THEREOF
NZ591824A (en) Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
Brogsitter et al. Twins in spirit: DOTATATE and high-affinity DOTATATE
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
AU2003247704A8 (en) Methods and compositions for diagnosing hepatocellular carcinoma
TW200833355A (en) Peptides that target to tumor blood vessels of lung cancer and applications thereof
NO20092366L (no) Radioaktivt merkede peptidbaserte forbindelser og anvendelser for disse